Targeted Medical Pharma, Inc. announced the launch of a new e-prescribing platform for the medical food, Theramine. The secure online e-prescribing portal is available to healthcare providers in the United States, interested in a clinically validated, peer reviewed, non-pharmacologic alternative to narcotic and NSAID pain medications for patients suffering from pain syndromes. Theramine is a medical food indicated for the dietary management of pain syndromes, and has been the subject of two double blind, randomized, multi center trials, which compared Theramine to low dose naproxen and ibuprofen.

256 subjects participated in the two studies across 10 independent sites that were randomized for treatment to receive Theramine alone, NSAID or a combination of both. In both studies, Theramine showed a statistically significant reduction in inflammation and improvement in low back pain than either naproxen at 250 mg daily or ibuprofen at 400 mg daily.